Organon & Co
NYSE:OGN
Organon & Co
Cash Interest Paid
Organon & Co
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Organon & Co
NYSE:OGN
|
Cash Interest Paid
$495m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash Interest Paid
$308m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Cash Interest Paid
$2.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash Interest Paid
$1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Organon & Co's Cash Interest Paid?
Cash Interest Paid
495m
USD
Based on the financial report for Dec 31, 2023, Organon & Co's Cash Interest Paid amounts to 495m USD.
What is Organon & Co's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 1Y
31%
Over the last year, the Cash Interest Paid growth was 31%.